-
Graphical Evidence Frameworks to Visualize the Holistic Value of Healthcare Interventions
Sep 9, 2025, 16:22 PM -
Navigating the Transition: What EU JCA Means for AMNOG Submissions in 2025 and Beyond
Sep 9, 2025, 16:22 PM -
A Retrospective Study of Treatment Use in Metastatic Colorectal Cancer (mCRC) Based on French Hospital Discharge Database
Sep 9, 2025, 16:22 PM -
Effect of Education Given to Nursing Students on Their Palliative Care Knowledge and Attitudes
Sep 9, 2025, 16:22 PM -
Assessing the Psychometric Performance of the Experimental EQ-TIPS V20 in Assessing the Health-Related Quality of Life of Stunted Children in Laos
Sep 9, 2025, 16:22 PM -
Shifts in Medicine Reimbursement in Türkiye: Who Pays for Medicines (2015-2022)?
Sep 9, 2025, 16:22 PM -
Characterizing Comorbidities and Co-Occurring Conditions in Adults with Generalized Anxiety Disorder in the United States
Sep 9, 2025, 16:22 PM -
Integrating Real-World Evidence Into Oncology HTA Submissions: Recent EU Examples
Sep 9, 2025, 16:22 PM -
Patient-Centered PICO Scoping in EU HTA: A Pilot Study for Structured Consensus Building Using a Delphi Panel
Sep 9, 2025, 16:22 PM -
Colorectal Cancer Mortality Overview in Mexico 1998-2023
Sep 9, 2025, 16:22 PM -
Feasibility of Building a Generic Partitioned Survival Model for Oncology: Essential Components and Technical Implementation
Sep 9, 2025, 16:22 PM -
Receipt of Biomarker Testing in Non-Small Cell Lung Cancer: Using Real-World Data to Identify Testing Gaps and Treatment Characteristics
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Early Liquid Biopsy in Patients With Suspicious Metastatic Lung Cancer Alongside the LIBELULE Randomized Phase III Trial
Sep 9, 2025, 16:22 PM -
Comparing Health-Related Quality of Life in Obese Patients With and Without Bariatric Surgery: A Cross-Sectional Study in a Multi-Ethnic Asian Population in Singapore
Sep 9, 2025, 16:22 PM -
Patient Pathways to Accessing Unregistered Medicines in Low-Priority Launch Markets
Sep 9, 2025, 16:22 PM -
Treatment Patterns, Inadequate Disease Control, and Burden/Unmet Need Among Adult Patients With Moderate-to-Severe Atopic Dermatitis: Results From the Adelphi Real-World Disease Specific Program
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Pembrolizumab for Patients With High-Risk Early Stage Triple-Negative Breast Cancer in Chile
Sep 9, 2025, 16:22 PM -
Caregiver Quality of Life in Orphan Drug Health Technology Assessment Submissions in Europe: A Comparative Analysis
Sep 9, 2025, 16:22 PM -
Hidden Obesity and Treatment Gaps in Japan: A Real-World Data Analysis
Sep 9, 2025, 16:22 PM -
Confidential Prices in NICE Health Technology Assessment: How Common Are They?
Sep 9, 2025, 16:22 PM
